Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Ongoing Oxidative Stress Causes Subclinical Neuronal Dysfunction in the Recovery Phase of EAE.
Interferon Beta Use and Disability Prevention in Relapsing-Remitting Multiple Sclerosis.
Dalfampridine extended release tablets: 1 year of postmarketing safety experience in the US.
Peripheral blood T cell dynamics predict relapse in multiple sclerosis patients on fingolimod.
Neurorestorative effect of FTY720 in a rat model of Alzheimer's disease: Comparison with Memantine.
Diagnostic Ability of a Linear Discriminant Function for Spectral-Domain Optical Coherence Tomography in Patients with Multiple Sclerosis.
The Ambivalent Role of Apoptosis in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis.
Response to disease modifying therapies in African Americans with multiple sclerosis.
Overview of the biology of type I interferons.
Targeting S1P receptors in experimental autoimmune encephalomyelitis in mice improves early deficits in locomotor activity and increases ultrasonic vocalisations.
Sub-Chronic Neuropathological and Biochemical Changes in Mouse Visual System after Repetitive Mild Traumatic Brain Injury.
Removing confounding factors via constraint-based clustering: An application to finding homogeneous groups of multiple sclerosis patients.
The Impact of Social Media on Dissemination and Implementation of Clinical Practice Guidelines: A Longitudinal Observational Study.
Cognitive and Behavioral Outcomes in Individuals With a History of Acute Disseminated Encephalomyelitis (ADEM).
FTY720 (Fingolimod) Attenuates Beta-amyloid Peptide (Aβ(42))-Induced Impairment of Spatial Learning and Memory in Rats.
Multi-compartment t2 relaxometry using a spatially constrained multi-gaussian model.
Prolongation of survival of rat cardiac allografts by T cell vaccination.
The role of tumour necrosis factor α in the pathogenesis of multiple sclerosis, and pentoxifylline as a possible pharmacotherapeutic intervention.
Association between pathological and MRI findings in multiple sclerosis.
Non-lesional white matter changes in pediatric multiple sclerosis and monophasic demyelinating disorders.
Update on PML and PML-IRIS Occurring in Multiple Sclerosis Patients Treated With Natalizumab.
[Inflammatory brain pseudotumor. A variant of demyelinating disease that simulates high-grade glioma].
Endocannabinoids and neurodegenerative diseases.
Medication withdrawal in relapsing-remitting multiple sclerosis: why not?
SymptoMScreen: A Tool for Rapid Assessment of Symptom Severity in MS Across Multiple Domains.

Pages